LATTOUF OMAR M has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets medical technology and machines are FED GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE ROSSIJSKIJ NAUCHNYJ TSENTR VOSSTANOVITELNAYA TRAVMATOLO, FOGAZZI DI VENTURELLI ANDREA & and THE FIFTH PEOPLE'S HOSPITAL OF SHANGHAI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Machines |
# | Technology | |
---|---|---|
#1 | Diagnosis and surgery | |
#2 | Implantable devices | |
#3 | Electrotherapy | |
#4 | Unspecified technologies | |
#5 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Lattouf Omar M | 21 |
#2 | Rahme Amin | 3 |
#3 | Hall Larry | 2 |
#4 | Hoyns Dirk | 2 |
#5 | Webster Robert M | 1 |
#6 | Ramey Carribeth | 1 |
#7 | Webster Sarah | 1 |
#8 | Shums Sameer | 1 |
Publication | Filing date | Title |
---|---|---|
US2020029983A1 | Clot retrievers and methods for deployment | |
WO2018118706A1 | Clot retrievers and methods for deployment | |
US2008249504A1 | Instrument port | |
US2007270793A1 | Methods for endocardial ablation | |
US2008004597A1 | Methods and devices for endocardiac access | |
US2007265702A1 | Percutaneous treatment for heart valves | |
US6978176B2 | Treatment for patient with congestive heart failure |